Concepedia

James E. Berger

JE

Statistics

Publications

4

Citations

113

H-Index

4

Active since

1993

Affiliations

Eli Lilly (United States)(Current)

Butler University

James E. Berger is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1993–2004

4

Publications

4

The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats

Kurt Rasmussen, H. Martin Martin, James E. Berger et al. · Neuropharmacology · 2004 · 38 citations

Medicine, Neuroscience, Pharmacology +12

The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle

Kurt Rasmussen, David R. Helton, James E. Berger et al. · Neuroreport · 1993 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +15

Central nervous system characterization of the new cholecystokininB antagonist LY288513

David R. Helton, James E. Berger, Janet F. Czachura et al. · Pharmacology Biochemistry and Behavior · 1996 · 30 citations

Medicine, Neuroscience, Pharmacology +13

James E. Berger · Twentieth Century Literature · 2000 · 13 citations

Natural Sciences, Mathematics, Physical Chemistry +1

1–4 of 4